F

Filana Therapeutics Inc
D

FLNA

1.44000
USD
-0.12
(-7.69%)
مغلق
حجم التداول
15,190
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
69,563,370
المقالات
المزيد

العنوان: Filana Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-relatedepilepsy.